1. Name and nature of the target (for preferred shares, the agreed issuance conditions such as dividend rate should also be indicated): Fubon Life Insurance Co., Ltd.'s 2026 First Issue Unsecured Cumulative Subordinated Ordinary Corporate Bonds (Updated) 2. Date of occurrence: 2026/4/28~2026/4/28 3. Date of board approval: January 28, 2026 4. Other approval dates: Not applicable 5. Quantity of transaction units, price per unit, and total transaction amount: Transaction quantity: 1,000 units (Updated) Unit price: Face value of NT$1 million per unit Total transaction amount: NT$1 billion (Updated) 6. Counterparty and its relationship with the company (if the counterparty is a natural person and not a related party of the company, disclosure of their name may be omitted): Counterparty: Fubon Life Insurance Co., Ltd. Relationship with the company: Both are subsidiaries of Fubon Financial Holding Co., Ltd. 7. If the counterparty is a related party, the reason for selecting the related party as the transaction object, the previous owner of the transferred asset, the relationship between the previous owner, the company, and the counterparty, the previous transfer date, and the transfer amount should also be announced: Acting as underwriter for the offering and issuance of Fubon Life Insurance Co., Ltd.'s 2026 First Issue Unsecured Cumulative Subordinated Ordinary Corporate Bonds (Updated) 8. If the owner of the transaction target has been a related party of the company within the last five years, the acquisition and disposal dates, prices, and relationships with the company at the time of the transaction for the related party should also be announced: Not applicable 9. Matters related to the disposal of claims (including types of collateral attached to the disposed claims, if the disposed claims are against a related party, the name of the related party and the book value of the disposed claims against that related party should also be announced): Not applicable 10. Disposal profit (or loss) (not applicable for acquisition of marketable securities) (if deferred, recognition status should be listed): Not applicable 11. Delivery or payment terms (including payment period and amount), contractual restrictions, and other important agreements: Delivery or payment terms: Paid in full on settlement date Contractual restrictions and other important agreements: None 12. Method of determining this transaction, reference basis for price determination, and decision-making unit: Method of determining this transaction: Negotiation Reference basis for price determination: Based on market conditions Decision-making unit: Determined according to the company's approval authority 13. Net worth per share of the target company for acquisition or disposal of marketable securities: Not applicable 14. As of now, the accumulated quantity, amount, shareholding ratio, and restricted rights (e.g., pledge status) of this transaction security (including this transaction): Fubon Financial Holding: None; Taipei Fubon Commercial Bank Quantity: 1,000 units (Updated) Amount: NT$1 billion (Updated) Restricted rights: None 15. As of now, the proportion of investment in marketable securities (including this transaction) listed in Article 3 of the "Regulations Governing the Acquisition and Disposal of Assets by Public Companies" to the total assets and equity attributable to owners of the parent company in the company's latest financial report, and the working capital in the latest financial report: Proportion to Fubon Financial Holding: 114.45%, 138.50%, Not applicable (Updated) Proportion to Taipei Fubon Bank: 29.95%, 428.07%, Not applicable (Updated) 16. Broker and brokerage fees: Not applicable 17. Specific purpose or use of acquisition or disposal: To act as underwriter for the offering and issuance of Fubon Life Insurance Co., Ltd.'s 2026 First Issue Unsecured Cumulative Subordinated Ordinary Corporate Bonds, and assist in the issuance (Updated) 18. Opinions of dissenting directors on this transaction: None 19. This transaction is a related party transaction: Yes 20. Date of approval by supervisor or audit committee: January 27, 2026 21. Accountant's opinion on this transaction being unreasonable: Not applicable 22. Name of accounting firm: Not applicable 23. Name of accountant: Not applicable 24. Accountant's practice certificate number: Not applicable 25. Does it involve a change in business model: No 26. Explanation of business model change: Not applicable 27. Transaction status with related parties in the past year and expected next year: The company's transactions with related parties in the past year were conducted in accordance with regulations, and transactions with related parties in the next year will depend on market conditions and mutual planning. 28. Source of funds: Working capital 29. Date of previous significant announcement on the same event: January 28, 2026 30. Other matters to be specified: None
FACT BOX
- Source: PR Times
- Category: Funding